advanced search  
Updated Sep. 1, 2010

 
 
Controlling Health Care Costs: U.S. Versus England
ISSUE: SEPTEMBER, 2010
As leaders argue about how to control the skyrocketing costs of cancer care, some say it is worthwhile to look at how other countries, such as England, cope. Over the past year and a half, England’s National Institute for Health and Clinical Excellence has rejected a number of cancer drugs for certain indications, concluding that patients would derive minimal benefits at an excessively high cost. read more
Vandetanib Active Against Metastatic Thyroid Cancer
ISSUE: SEPTEMBER, 2010
The first Phase III trial with a tyrosine kinase inhibitor in advanced or metastatic medullary thyroid cancer has revealed that vandetanib (Zactima, AstraZeneca) can significantly improve progression-free survival. read more
Experts Debate Use of Maintenance Therapy for NSCLC
ISSUE: SEPTEMBER, 2010
Should maintenance therapy become the standard of care for advanced non-small cell lung cancer? This question was the topic of a lively debate at the annual meeting of the American Society of Clinical Oncology. Although some believe maintenance therapy is a must, others say it only is valuable in certain patients and may be cost-prohibitive. read more
Public Protest Leads CMS to Redefine EMR ‘Meaningful Use’
ISSUE: SEPTEMBER, 2010
Hospitals and physician practices have been promised financial incentives if they can demonstrate “meaningful use” of their certified electronic health records. Now, due to a public outcry, practices will have far greater flexibility in demonstrating “meaningful use” under a final rule recently issued by the Centers for Medicare & Medicaid Services. read more
 


•  Drug Combination Improves Survival in Pancreatic Cancer

•  Experts Highlight ‘Need-to-Know’ ASCO Meeting News

•  Studies Challenge Value of Breast Cancer Procedures

•  In Multiple Myeloma, Maintenance Therapy After Transplant Improves PFS

•  Chemotherapy Options in the Management of Platinum-Sensitive Recurrent

•  August 2010 - Digital Edition

•  Tool Improves Patient Access to Oncology Drugs in Development

•  Controlling Health Care Costs: U.S. Versus England

•  Around the Water Cooler

•  Experts Debate Use of Maintenance Therapy for NSCLC

 
SEPTEMBER, 2010
FREE PRINT SUBSCRIPTION
 
 
EDUCATIONAL REVIEW
Expanding Treatment Options for Patients With Chronic Myeloid Leukemia
SOLID TUMORS
Vandetanib Active Against Metastatic Thy...  [9/2010] (new)
Experts Debate Use of Maintenance Therap...  [9/2010] (new)
Oncoplasty Interest Grows as Breast Canc...  [9/2010] (new)
more 
HEMATOLOGIC MALIGNANCIES
Biosensor Aims To Improve CML Therapy ...  [9/2010] (new)
In Multiple Myeloma, Maintenance Therapy After Tra...  [8/2010]
Novel Vincristine Formulation Improves Outcomes in...  [8/2010]
more 
SUPPORTIVE CARE
New Guidelines Issued for Clostridium di...  [9/2010] (new)
Investigational Agent Stops Potentially Fatal 5-FU...  [7/2010]
Concern Revving Up Over REMS For ESAs ...  [6/2010]
more 
POLICY AND MANAGEMENT
Controlling Health Care Costs: U.S. Vers...  [9/2010] (new)
Public Protest Leads CMS to Redefine EMR...  [9/2010] (new)
Patients Give High Marks to EHRs ...  [9/2010] (new)
more 

 
 
home  |  about us  |  advertise  |  contact  |  publications
 


Copyright © 2005 - 2010 McMahon Publishing unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.